Release Date: 24/01/11 08:29 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 2.57MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%